Karine Mardon

1.1k total citations
59 papers, 819 citations indexed

About

Karine Mardon is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Karine Mardon has authored 59 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Cellular and Molecular Neuroscience and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Karine Mardon's work include Receptor Mechanisms and Signaling (12 papers), Neuroscience and Neuropharmacology Research (7 papers) and Pharmacological Receptor Mechanisms and Effects (6 papers). Karine Mardon is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Neuroscience and Neuropharmacology Research (7 papers) and Pharmacological Receptor Mechanisms and Effects (6 papers). Karine Mardon collaborates with scholars based in Australia, France and United States. Karine Mardon's co-authors include Pascal Merlet, André Syrota, Vera Weisbecker, Filomena Mattner, B. Mazièré, Rikki N. Waterhouse, Andrew Katsifis, Christian Loc’h, Nyoman D. Kurniawan and Kristofer J. Thurecht and has published in prestigious journals such as Brain, Neurology and Scientific Reports.

In The Last Decade

Karine Mardon

55 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karine Mardon Australia 18 222 158 116 94 89 59 819
Amaury Pupo United States 17 677 3.0× 158 1.0× 107 0.9× 197 2.1× 26 0.3× 36 1.3k
Christine E. Pullar United States 20 624 2.8× 168 1.1× 266 2.3× 23 0.2× 31 0.3× 30 1.4k
Albert Kao Taiwan 21 268 1.2× 265 1.7× 78 0.7× 41 0.4× 5 0.1× 84 1.4k
Urmas Roostalu Denmark 17 552 2.5× 35 0.2× 116 1.0× 156 1.7× 11 0.1× 38 1.1k
Farhana E. Suleman South Africa 9 344 1.5× 49 0.3× 183 1.6× 173 1.8× 12 0.1× 45 1.0k
Maura Castagna Italy 22 342 1.5× 197 1.2× 356 3.1× 103 1.1× 6 0.1× 95 1.4k
J. Rostgaard Denmark 24 434 2.0× 26 0.2× 59 0.5× 73 0.8× 16 0.2× 53 1.3k
Susumu Tanaka Japan 18 369 1.7× 39 0.2× 217 1.9× 103 1.1× 4 0.0× 162 1.5k
Svetlana Lublinsky Israel 15 143 0.6× 81 0.5× 138 1.2× 32 0.3× 36 0.4× 22 781
Shigeo Takeuchi Japan 15 154 0.7× 32 0.2× 87 0.8× 79 0.8× 4 0.0× 58 729

Countries citing papers authored by Karine Mardon

Since Specialization
Citations

This map shows the geographic impact of Karine Mardon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karine Mardon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karine Mardon more than expected).

Fields of papers citing papers by Karine Mardon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karine Mardon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karine Mardon. The network helps show where Karine Mardon may publish in the future.

Co-authorship network of co-authors of Karine Mardon

This figure shows the co-authorship network connecting the top 25 collaborators of Karine Mardon. A scholar is included among the top collaborators of Karine Mardon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karine Mardon. Karine Mardon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Albornoz, Eduardo A., Richard D. Gordon, Ibrahim Javed, et al.. (2025). Microglial Complement C5aR1 signalling drives inflammasome mediated neuropathology in Parkinson’s disease. Immunobiology. 230(4). 152955–152955.
2.
Albornoz, Eduardo A., Karine Mardon, Rajiv Bhalla, et al.. (2025). PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson’s disease models. Brain.
3.
Forgham, Helen, Jiayuan Zhu, Xumin Huang, et al.. (2024). Multifunctional Fluoropolymer‐Engineered Magnetic Nanoparticles to Facilitate Blood‐Brain Barrier Penetration and Effective Gene Silencing in Medulloblastoma. Advanced Science. 11(25). e2401340–e2401340. 13 indexed citations
4.
Ghosh, Saikat, Zachary H. Houston, Nicholas L. Fletcher, et al.. (2024). A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements. Chemical Science. 15(30). 11748–11760. 5 indexed citations
5.
Weisbecker, Vera, Robin M. D. Beck, Thomas Guillerme, et al.. (2023). Multiple modes of inference reveal less phylogenetic signal in marsupial basicranial shape compared with the rest of the cranium. Philosophical Transactions of the Royal Society B Biological Sciences. 378(1880). 20220085–20220085. 7 indexed citations
6.
Jing, Yu, et al.. (2023). Visualisation of [11C]CO2 storage in coal with positron emission tomography imaging. Fuel. 356. 129511–129511. 2 indexed citations
8.
Marasini, Nirmal, Changkui Fu, Nicholas L. Fletcher, et al.. (2020). The Impact of Polymer Size and Cleavability on the Intravenous Pharmacokinetics of PEG-Based Hyperbranched Polymers in Rats. Nanomaterials. 10(12). 2452–2452. 10 indexed citations
9.
Bhalla, Rajiv, Gary Cowin, Xin Song, et al.. (2020). GABAa receptor density alterations revealed in a mouse model of early moderate prenatal ethanol exposure using [18F]AH114726. Nuclear Medicine and Biology. 88-89. 44–51. 3 indexed citations
10.
Mardon, Karine, Jacqueline M. Orian, Gisbert Weckbecker, et al.. (2019). Efficient Distribution of a Novel Zirconium-89 Labeled Anti-cd20 Antibody Following Subcutaneous and Intravenous Administration in Control and Experimental Autoimmune Encephalomyelitis-Variant Mice. Frontiers in Immunology. 10. 2437–2437. 7 indexed citations
11.
Tieng, Quang M., Karine Mardon, Christine Zhang, et al.. (2019). Magnetic Resonance Imaging and Micro-Computed Tomography reveal brain morphological abnormalities in a mouse model of early moderate prenatal ethanol exposure. Neurotoxicology and Teratology. 77. 106849–106849. 4 indexed citations
12.
Bhalla, Rajiv, Karine Mardon, Jacqueline M. Orian, et al.. (2018). Imaging and biodistribution of a novel anti-CD20 antibody following subcutaneous administration in control and experimental autoimmune encephalomyelitis-variant mice. Multiple Sclerosis Journal. 24. 588–589. 1 indexed citations
14.
Chong, Suyinn, et al.. (2017). Radiological studies of fetal alcohol spectrum disorders in humans and animal models: An updated comprehensive review. Magnetic Resonance Imaging. 43. 10–26. 35 indexed citations
15.
Guidi, Sandra, Fiorenza Stagni, Patrizia Bianchi, et al.. (2013). Prenatal pharmacotherapy rescues brain development in a Down’s syndrome mouse model. Brain. 137(2). 380–401. 66 indexed citations
16.
Kassiou, Michael, Christian Loc’h, Michel Bottlaender, et al.. (2002). (+)-[76Br]A-69024: a non-benzazepine radioligand for studies of dopamine D1 receptors using PET. Nuclear Medicine and Biology. 29(3). 295–302. 8 indexed citations
17.
Mardon, Karine, et al.. (1999). Effects of streptozotocin-induced diabetes on neuronal sigma receptors in the rat brain. Life Sciences. 65(23). PL281–PL286. 10 indexed citations
18.
Nguyen, Vu, Karine Mardon, Michael Kassiou, & MacDonald J. Christie. (1999). In vitro and in vivo characterisation of [3H]ANSTO-14 binding to the σ1 binding sites. Nuclear Medicine and Biology. 26(2). 209–215. 5 indexed citations
19.
Raffel, David M., Christian Loc’h, Karine Mardon, B. Mazièré, & André Syrota. (1998). Kinetics of the norepinephrine analog [76Br]-metabromobenzylguanidine in isolated working rat heart. Nuclear Medicine and Biology. 25(1). 1–16. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026